Cravatex Limited has announced the re-appointment of Mr. Divakar G. Kamath as Executive Director and Chief Financial Officer for an additional three-year term. The decision was taken by the Board of Directors during their meeting held on March 30, 2026, which commenced at 12.30 pm IST and concluded at 12.40 pm IST.

Board Decision and Term Details

The re-appointment was made on the recommendation of the Nomination and Remuneration Committee. Mr. Kamath, who holds Director Identification Number (DIN) 08730430, will serve as Executive Director and CFO for a period of 3 years with effect from April 1, 2026 to March 31, 2029. The appointment is subject to approval by the members of the company.

Professional Background

Mr. Divakar G. Kamath brings extensive experience to his role, with qualifications including a graduate degree in Economics, Law and DFM from Mumbai University, along with certification as a Certified Associate of Indian Institute of Bankers (CAIIB). His professional journey spans approximately 32 years, primarily in Corporate Banking Business across reputed Public Sector and Private Sector Banks.

Career Highlights

Mr. Kamath joined Cravatex Limited in 2012 as Chief Financial Officer. Prior to this role, he served as Senior Vice President and pan India Head of Small and Medium Enterprise at Axis Bank Ltd. His expertise extends beyond banking and finance to include substantial exposure in legal matters, with Finance and Risk Management being his areas of academic interest.

Regulatory Compliance

The company has confirmed that Mr. Kamath is not related to any other Directors of the company. In accordance with BSE Circular no. LIST/COMP/14/2018-19 dated June 20, 2018, the company has affirmed that Mr. Kamath is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.

The disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring compliance with all regulatory requirements for such appointments.

Cravatex Limited has announced its unaudited financial results for the third quarter of FY26 ended December 31, 2025, demonstrating strong operational performance across both standalone and consolidated metrics. The Board of Directors approved these results during their meeting held on February 12, 2026.

Standalone Financial Performance

The company's standalone operations showed impressive growth during Q3FY26. Revenue from operations increased significantly by 23.40% to ₹313.12 lacs compared to ₹253.76 lacs in the corresponding quarter of the previous year.

The company's total expenses for Q3FY26 stood at ₹406.12 lacs compared to ₹352.02 lacs in Q3FY25. Purchase of stock-in-trade remained the largest expense component at ₹310.04 lacs, followed by employee benefits expense at ₹41.10 lacs.

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, Cravatex reported standalone revenue from operations of ₹709.84 lacs compared to ₹479.59 lacs in the corresponding period of FY25, representing a growth of 48.02%. The net profit for the nine-month period was ₹341.25 lacs compared to ₹484.54 lacs in the previous year.

Consolidated Results

On a consolidated basis, the company's performance was equally robust. Revenue from operations for Q3FY26 reached ₹3,678.92 lacs compared to ₹3,243.07 lacs in Q3FY25, marking a growth of 13.44%.

The consolidated results include contributions from the company's subsidiaries BB (UK) Limited and BB Euro GmbH. For the nine months ended December 31, 2025, consolidated revenue from operations was ₹11,136.13 lacs compared to ₹11,324.29 lacs in the corresponding period of FY25.

Operational Highlights

The company operates in a single primary business segment and maintains its focus on operational efficiency. Employee benefits expense on a consolidated basis increased to ₹758.83 lacs in Q3FY26 from ₹637.25 lacs in Q3FY25, reflecting the company's investment in human resources.

Depreciation and amortisation expense on a consolidated basis was ₹37.63 lacs for Q3FY26 compared to ₹39.69 lacs in the previous year quarter. Finance costs remained controlled at ₹8.69 lacs for the quarter.

Regulatory Compliance

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and have undergone limited review by the statutory auditors GPS & Associates. The results comply with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.